Arax Advisory Partners’s BioMarin Pharmaceuticals BMRN Stock Holding History
Bought
Maintained
Sold
Other funds holding BMRN
Arax Advisory Partners's BMRN Position: Q3 2026 in Review
Arax Advisory Partners reported 21,304 shares of BioMarin Pharmaceuticals (BMRN) worth $1.28M in Q3 2026. The position accounts for 0.01% of the portfolio, ranked #1204.
Arax Advisory Partners first reported a position in BMRN in Q4 2016 and has held it in 21 quarters since. The position peaked at $5.6M in Q3 2025. 567 funds tracked by Wall St. Rank hold BMRN as of Q3 2026.
- Arax Advisory Partners held 21,304 shares of BioMarin Pharmaceuticals worth $1.28M as of Q3 2026.
- BioMarin Pharmaceuticals made up 0.01% of Arax Advisory Partners's portfolio in Q3 2026, its #1204 holding.
- Arax Advisory Partners first reported a position in BioMarin Pharmaceuticals in Q4 2016 and has held it in 21 quarters since.
- Arax Advisory Partners's BioMarin Pharmaceuticals position peaked at $5.6M in Q3 2025.
- 567 funds tracked by Wall St. Rank held BioMarin Pharmaceuticals as of Q3 2026.
Based on Arax Advisory Partners's 13F filing for Q3 2026, filed 12 Nov 2026.